![Harout Semerjian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Harout Semerjian
Vorstandsvorsitzender bei
GERON CORPORATION
Profil
Mr. Harout Semerjian is a President, Chief Executive Officer & Director at Geron Corp.
He is on the Board of Directors at Geron Corp.
and Biotechnology Innovation Organization.
Mr. Semerjian was previously employed as a President, Chief Executive Officer & Director by GlycoMimetics, Inc., a President, Chief Executive Officer & Director by Immunomedics, Inc., a Chief Commercial Officer & Executive VP by Ipsen Pharma SAS, and a Chief Commercial Officer & Executive VP by Ipsen SA. He received his undergraduate degree from Lebanese American University, an MBA from Queen's University and an MBA from Cornell University.
Aktuelle Nachrichten zu Harout Semerjian
Aktive Positionen von Harout Semerjian
| Unternehmen | Position | Beginn |
|---|---|---|
| GERON CORPORATION | Vorstandsvorsitzender | 07.08.2025 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | 01.10.2023 |
Ehemalige bekannte Positionen von Harout Semerjian
| Unternehmen | Position | Ende |
|---|---|---|
GlycoMimetics, Inc.
 GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Vorstandsvorsitzender | 21.02.2025 |
| IMMUNOMEDICS, INC. | Vorstandsvorsitzender | 27.05.2020 |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 30.04.2020 |
| IPSEN | Corporate Officer/Principal | 01.04.2020 |
Ausbildung von Harout Semerjian
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
Lebanese American University
 Lebanese American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Wählen Sie MarketScreener 
